PURPOSE OF REVIEW: The differentiation of pluripotent and multipotent stem cells into insulin-producing cells has the potential to create a renewable supply of replacement beta cells with tremendous utility in the treatment of diabetes. The purpose of this review is to summarize recent advancements in the field, with emphasis on the limitations of this technology as it relates to the beta cell. RECENT FINDINGS: Multiple groups have developed successful in-vitro protocols to differentiate human embryonic stem cells and selected tissue specific stem cells into progenitors capable of insulin production and glucose-stimulated insulin secretion. The resulting cells are immature beta cell-like cells that coexpress multiple islet hormones and lack the full complement of genes necessary for normal function. Protocols that include in-vivo maturation in immune-compromised mice produce cells with a more mature phenotype. SUMMARY: Although tremendous progress has been made in differentiating stem cells into insulin-producing cells, there is still more research needed to produce a fully functional adult beta cell.
PURPOSE OF REVIEW: The differentiation of pluripotent and multipotent stem cells into insulin-producing cells has the potential to create a renewable supply of replacement beta cells with tremendous utility in the treatment of diabetes. The purpose of this review is to summarize recent advancements in the field, with emphasis on the limitations of this technology as it relates to the beta cell. RECENT FINDINGS: Multiple groups have developed successful in-vitro protocols to differentiate human embryonic stem cells and selected tissue specific stem cells into progenitors capable of insulin production and glucose-stimulated insulin secretion. The resulting cells are immature beta cell-like cells that coexpress multiple islet hormones and lack the full complement of genes necessary for normal function. Protocols that include in-vivo maturation in immune-compromised mice produce cells with a more mature phenotype. SUMMARY: Although tremendous progress has been made in differentiating stem cells into insulin-producing cells, there is still more research needed to produce a fully functional adult beta cell.
Authors: Kevin A D'Amour; Alan D Agulnick; Susan Eliazer; Olivia G Kelly; Evert Kroon; Emmanuel E Baetge Journal: Nat Biotechnol Date: 2005-10-28 Impact factor: 54.908
Authors: Bronislava R Gedulin; Svetlana E Nikoulina; Pamela A Smith; George Gedulin; Loretta L Nielsen; Alain D Baron; David G Parkes; Andrew A Young Journal: Endocrinology Date: 2004-12-23 Impact factor: 4.736
Authors: Michael A Hale; Hideaki Kagami; Ling Shi; Andrew M Holland; Hans-Peter Elsässer; Robert E Hammer; Raymond J MacDonald Journal: Dev Biol Date: 2005-10-01 Impact factor: 3.582
Authors: Aurélie V Poll; Christophe E Pierreux; Ludmilla Lokmane; Cécile Haumaitre; Younes Achouri; Patrick Jacquemin; Guy G Rousseau; Silvia Cereghini; Frédéric P Lemaigre Journal: Diabetes Date: 2006-01 Impact factor: 9.461
Authors: Maria E Wilson; Katherine Y Yang; Anna Kalousova; Janet Lau; Yasuhiro Kosaka; Francis C Lynn; Juehu Wang; Caroline Mrejen; Vasso Episkopou; Hans C Clevers; Michael S German Journal: Diabetes Date: 2005-12 Impact factor: 9.461
Authors: D Freimark; P Pino-Grace; S Pohl; C Weber; C Wallrapp; P Geigle; R Pörtner; P Czermak Journal: Transfus Med Hemother Date: 2010-03-08 Impact factor: 3.747
Authors: Mahmoud M Gabr; Mahmoud M Zakaria; Ayman F Refaie; Sherry M Khater; Sylvia A Ashamallah; Amani M Ismail; Sawsan M El-Halawani; Mohamed A Ghoneim Journal: Biomed Res Int Date: 2015-05-12 Impact factor: 3.411